SMAM
AVNS icon

Sugar Maple Asset Management’s Avanos Medical AVNS Stock Holding History

Sugar Maple Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18
Closed -$287 – 101
2024
Q4 		$287 Buy
+18
New +$356 ﹤0.01% 406

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sugar Maple Asset Management's AVNS Position: Q1 2025 in Review

Sugar Maple Asset Management sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 18 shares — an estimated $287 sold.

Sugar Maple Asset Management first reported a position in AVNS in Q4 2024 and held it in 1 quarter. The position peaked at $287 in Q4 2024. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

  • Sugar Maple Asset Management reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
  • Sugar Maple Asset Management sold 18 Avanos Medical shares in Q1 2025, an estimated $287.
  • Sugar Maple Asset Management first reported a position in Avanos Medical in Q4 2024 and held it in 1 quarter.
  • Sugar Maple Asset Management's Avanos Medical position peaked at $287 in Q4 2024.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Sugar Maple Asset Management's 13F filing for Q1 2025, filed 10 Apr 2025.